Quotes 5-day view Delayed Nyse
10/19/2020
10/20/2020
10/21/2020
10/22/2020
10/23/2020
Date
39.07(c)
39.34(c)
39.13(c)
40.61(c)
40.94(c)
Last
3 745 166
3 865 995
5 834 670
4 917 046
4 804 111
Volume
-0.53% +0.69% -0.53% +3.78% +0.81% Change
Sales 2020
61 289 M - -
Net income 2020
7 352 M - -
Net Debt 2020
-
-
-
P/E ratio 2020
5,34x
Yield 2020
4,44%
Sales 2021
67 598 M - -
Net income 2021
4 604 M - -
Net Debt 2021
-
-
-
P/E ratio 2021
7,82x
Yield 2021
4,65%
Capitalization
37 160 M 37 160 M -
Capi. / Sales 2020
0,61x
Capi. / Sales 2021
0,55x
Nbr of Employees
-
Free-Float
63,8%
MetLife, Inc. is one of the leading American insurance groups. Premiums issued break down by activity as follows:
- life insurance (57%): sales of savings, pre-planning, and annuities insurance policies;
- accident and health insurance (34.3%);
- property and casualty insurance (8.7%).
Premiums are distributed geographically as follows: the United States (63.6%), Asia (15.7%), Latin America (6.5%), Europe/Middle...
Notations Surperformance© of MetLife, Inc.
Trading Rating : Investor Rating :
All news about METLIFE, INC.
News in other languages on METLIFE, INC.
Analyst Recommendations on METLIFE, INC.
MetLife to buy PE-backed Versant Health for $1.68 billion
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends METLIFE, INC.
Short Term Mid-Term Long Term Trends Bullish Neutral Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
12
Average target price
45,42 $
Last Close Price
40,94 $
Spread / Highest target
44,1%
Spread / Average Target
10,9%
Spread / Lowest Target
-4,74%
Please enable JavaScript in your browser's settings to use dynamic charts.
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
